The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition
Open accessAbstract
Peritoneal metastasis is a primary metastatic route for gastric cancers, and the mechanisms underlying this process are still unclear. Peritoneal mesothelial cells (PMCs) undergo mesothelial-to-mesenchymal transition (MMT) to provide a favorable environment for metastatic cancer cells. In this study, we investigated how the exosomal miR-21-5p induces MMT and promotes peritoneal metastasis. Gastric cancer (GC)-derived exosomes were identified by transmission electron microscopy and western blot analysis, then the uptake of exosomes was confirmed by PKH-67 staining. The expression of miR-21-5p and SMAD7 were measured by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot, and the interactions between miR-21-5p and its target genes SMAD7 were confirmed by Luciferase reporter assays. The MMT of PMCs was determined by invasion assays, adhesion assays, immunofluorescent assay, and western blot. Meanwhile, mouse model of tumor peritoneal dissemination model was performed to investigate the role of exosomal miR-21-5p in peritoneal metastasis in vivo. We found that PMCs could internalize GC-derived exosomal miR-21-5p and led to increased levels of miR-21-5p in PMCs. Through various types of in vitro and in vivo assays, we confirmed that exosomal miR-21-5p was able to induce MMT of PMCs and promote tumor peritoneal metastasis. Moreover, our study revealed that this process was promoted by exosomal miR-21-5p through activating TGF-β/Smad pathway via targeting SMAD7. Altogether, our data suggest that exosomal miR-21-5p induces MMT of PMCs and promote cancer peritoneal dissemination by targeting SMAD7. The exosomal miR-21-5p may be a novel therapeutic target for GC peritoneal metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“microRNA's presence in exosomes have been already reported in different cells and cancer types (44–50).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lv, Z., Wang, H., Dong, Q., Kong, B., Li, J., Yang, Z., Qu, H., Cao, W., & Xu, H. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1583-0 · Cited by 21
RetractedValadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
Becker, A., Thakur, B. K., Weiss, J. M., Kim, H. S., Peinado, H., & Lyden, D. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.009 · Cited by 2,003
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R. L., Itoh, S., Kawabata, M., Heldin, N., Heldin, C., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,796
Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205
ExoCarta 2012: database of exosomal proteins, RNA and lipids
Mathivanan, S., Fahner, C. J., Reid, G. E., & Simpson, R. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr828 · Cited by 1,096
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
Trams, E. G., Lauter, C. J., Salem, N., & Heine, U. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90512-5 · Cited by 1,094
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Almhanna, K., Bentrem, D. J., Chao, J., Das, P., Denlinger, C. S., Fanta, P. T., Farjah, F., Fuchs, C. S., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0137 · Cited by 931
Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes
Wubbolts, R., Leckie, R. S., Veenhuizen, P. T. M., Schwarzmann, G., Möbius, W., Hoernschemeyer, J., Slot, J.-W., Geuze, H. J., & Stoorvogel, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207550200 · Cited by 886
Peritoneal Dialysis and Epithelial-to-Mesenchymal Transition of Mesothelial Cells
Yáñez‐Mó, M., Lara‐Pezzi, E., Selgas, R., Ramírez‐Huesca, M., Domı́nguez-Jiménez, C., Jiménez-Heffernan, J. A., Aguilera, A. I., Sánchez-Tomero, J. A., Bajo, M. A., Álvarez, V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020809 · Cited by 778
Gastpar, R., Gehrmann, M., Bausero, M. A., Asea, A. A. A., Groß, C. C., Schroeder, J. A., & Multhoff, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3804 · Cited by 696
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J. D., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1625 · Cited by 534
Self-citationDirect Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Asaga, S., Kuo, C. T., Nguyen, T. T., Terpenning, M., Giuliano, A. E., & Hoon, D. S. �. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.151845 · Cited by 455
The UCSC Cancer Genomics Browser: update 2015
Goldman, M. J., Craft, B., Swatloski, T., Cline, M., Morozova, O., Diekhans, M., Haussler, D. H., & Zhu, J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1073 · Cited by 371
The challenge of screening for early gastric cancer in China
Zong, L., Abe, M., Seto, Y., & Ji, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32226-7 · Cited by 350
Teplyuk, N. M., Mollenhauer, B., Gabriely, G., Giese, A., Kim, E. L., Smolsky, M., Kim, R. Y., Saria, M. G., Pastorino, S., Kesari, S. P., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos074 · Cited by 304
Mesothelial Cells Promote Early Ovarian Cancer Metastasis through Fibronectin Secretion
Kenny, H. A., Chiang, C.-Y., White, E. A., Schryver, E. M., Habis, M., Romero, I. L., Ladanyi, A., Penicka, C. V., George, J., Matlin, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74778 · Cited by 303
Smith, A., Iwanaga, R., Drasin, D. J., Micalizzi, D. S., Vartuli, R. L., Tan, A. C., & Ford, H. L. (2012) · Oncogene · doi:10.1038/onc.2012.11 · Cited by 293
Wei, F., Ma, C., Zhou, T., Dong, X., Luo, Q., Geng, L., Ding, L., Zhang, Y., Zhang, L., Li, N., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0694-8 · Cited by 245
Self-citationPresent status of human papillomavirus vaccine development and implementation
Herrero, R., González, P., & Markowitz, L. E. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70481-4 · Cited by 220
Sandoval, P., Jiménez-Heffernan, J. A., Rynne‐Vidal, Á., Lozano, M. L. P., Gilsanz, Á., Ruiz‐Carpio, V., Reyes, R., García‐Bordas, J., Stamatakis, K., Dotor, J., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4281 · Cited by 189
Tokuhisa, M., Ichikawa, Y., Kosaka, N., Ochiya, T., Yashiro, M., Hirakawa, K., Kosaka, T., Makino, H., Akiyama, H., Kunisaki, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130472 · Cited by 183
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
Zhou, F., Drabsch, Y., Dekker, T. J. A., de Vinuesa, A. G., Li, Y., Hawinkels, L. J. A. C., Sheppard, K.-A., Goumans, M., Luwor, R. B., de Vries, C. J. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4388 · Cited by 182
MiR-21/Smad 7 signaling determines TGF-β1-induced CAF formation
Li, Q., Zhang, D., Wang, Y., Sun, P., Hou, X., Larner, J., Xiong, W., & Mi, J. (2013) · Scientific Reports · doi:10.1038/srep02038 · Cited by 179
Self-citationLiao, J., Liu, R., SHI, Y.-J., Yin, L., & Pu, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3453 · Cited by 150
Yu, J., Lei, R., Zhuang, X., Li, X., Li, G., Lev, S., Segura, M. F., Zhang, X., & Hu, G. (2016) · Nature Communications · doi:10.1038/ncomms13884 · Cited by 126
Tchernitsa, O. I., Kasajima, A., Schäfer, R., Kuban, R., Ungethüm, U., Győrffy, B., Neumann, U. P., Simon, É., Weichert, W., Ebert, M. P., et al. (2010) · The Journal of Pathology · doi:10.1002/path.2759 · Cited by 126
Surgical treatment for peritoneal carcinomatosis from gastric cancer
Yonemura, Y., Endou, Y., Sasaki, T., Hirano, M., Mizumoto, A., Matsuda, T., Takao, N., Ichinose, M., Miura, M., & Li, Y. (2010) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2010.09.006 · Cited by 118
Do, T.-V., Kubba, L. A., Du, H., Sturgis, C. D., & Woodruff, T. K. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0294 · Cited by 118
Rynne‐Vidal, Á., Yeung, C. L. A., Jiménez-Heffernan, J. A., Lozano, M. L. P., Cremades‐Jimeno, L., Bárcena, C., García, I. C., Fernández‐Chacón, C., Yeung, T. L., Mok, S. C., et al. (2017) · The Journal of Pathology · doi:10.1002/path.4889 · Cited by 113
Gastric cancer‐derived exosomes promote peritoneal metastasis by destroying the mesothelial barrier
Deng, G., Qu, J., Zhang, Y., Che, X., Cheng, Y., Fan, Y., Zhang, S., Di, N., Liu, Y., & Qu, X. (2017) · FEBS Letters · doi:10.1002/1873-3468.12722 · Cited by 108
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
Rynne‐Vidal, Á., Jiménez-Heffernan, J. A., Fernández‐Chacón, C., López‐Cabrera, M., & Sandoval, P. (2015) · Cancers · doi:10.3390/cancers7040872 · Cited by 103
Wei, M., Yang, T., Chen, X., Wu, Y., Deng, X., He, W., Yang, J., & Wang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.15040 · Cited by 83
Rougier, J., Guia, S., Hagège, J., Nguyen, G., & Ronco, P. M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00955.x · Cited by 73
PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage
Sandoval, P., Loureiro, J., Gónzalez-Mateo, G. T., Lozano, M. L. P., Maldonado-Rodrı́guez, A., Sánchez-Tomero, J. A., Mendoza, L., Santamaría, B., Ortíz, A., Ruiz‐Ortega, M., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.111 · Cited by 69
Hyperosmolality suppresses but TGFβ1 increases MMP9 in human peritoneal mesothelial cells
Rougier, J., Moullier, P., Piedagnel, R., Ronco, P. M., & Guia, W. T. T. A. O. S. (1997) · Kidney International · doi:10.1038/ki.1997.42 · Cited by 67
ICAM-1 Mediated Peritoneal Carcinomatosis, A Target for Therapeutic Intervention
Alkhamesi, N. A., Ziprin, P., Pfistermüller, K. L. M., Peck, D. H., & Darzi, A. W. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2893-8 · Cited by 64
Sako, A., Kitayama, J., Yamaguchi, H., Kaisaki, S., Suzuki, H., Fukatsu, K., Fujii, S., & Nagawa, H. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00307-x · Cited by 61
Zhang, L., Li, Z., He, W., Xu, L.-D., Wang, J., Shi, J., & Sheng, M. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430332 · Cited by 56
Self-citationJayne, D. G., Perry, S., Morrison, E. E., Farmery, S. M., & Guillou, P. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1068 · Cited by 56
Nakamura, M., Ono, Y. J., Kanemura, M., Tanaka, T., Hayashi, M., Terai, Y., & Ohmichi, M. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.08.010 · Cited by 51
Characterization of exosomal RNAs derived from human gastric cancer cells by deep sequencing
Ren, J. L., Zhou, Q., Li, H. R., Li, J., Pang, L., Su, L., Gu, Q., Zhu, Z., & Liu, B. (2017) · Tumor Biology · doi:10.1177/1010428317695012 · Cited by 36
Subramanian, A., Gupta, V. G., Sarkar, S., Maity, G., Banerjee, S., Ghosh, A., Harris, L., Christenson, L. K., Hung, W., Bansal, A. K., et al. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0338-6 · Cited by 24
Chu, Y., Wang, Y., Zheng, Z., Lin, Y., He, R., Liu, J., & Yang, X. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00762 · Cited by 18
Cited by
Sorted by citations
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Al-Marzooqi, S. K., Jerobin, J., Altemani, F. H., Algehainy, N. A., Alanazi, M. A., Abou‐Samra, A., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,545
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Li, C., Ni, Y., Xu, H., Xiang, Q., Zhao, Y. Q., Zhan, J., He, J., Li, S., & Liu, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00779-x · Cited by 424
Expression, regulation, and function of exosome‐derived miRNAs in cancer progression and therapy
Li, B., Cao, Y. Q., Sun, M., & Feng, H. (2021) · The FASEB Journal · doi:10.1096/fj.202100294rr · Cited by 267
Self-citationPre-metastatic niche: formation, characteristics and therapeutic implication
Wang, Y., Jia, J., Wang, F., Fang, Y., Yang, Y., Zhou, Q., Yuan, W., Gu, X., Hu, J., & Yang, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01937-7 · Cited by 289
Exosomes in gastric cancer: roles, mechanisms, and applications
Fu, M., Gu, J., Jiang, P., Qian, H., Xu, W., & Zhang, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1001-7 · Cited by 238
Metadata
- Authors
- Li, Q., Li, B., Li, Q., Wei, S., He, Z., Huang, X., Wang, L., Xia, Y., Xu, Z., Li, Z., Wang, W., Yang, L., Zhang, D., & Xu, Z.
- Affiliations
- Jiangsu Province Hospital (CN)
- Corresponding author
- Zhang, Diancai
- ORCID
- Venue
- Cell Death & Disease
- Published
- 2018-08-28
- Volume
- 9
- Issue
- 9
- Pages
- 854-854
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC6113299
- OpenAlex
- W2889190369
- Cited by
- 219
- References
- 47
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 31 · 2023: 34 · 2022: 45 · 2021: 46 · 2020: 17 · 2019: 14
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (JX10231801, 30901443)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, JX10231801, JX 10231801)
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- gastric cancer, peritoneal carcinomatosis, exosomes, miR-21-5p, mesothelial-to-mesenchymal transition, peritoneal mesothelial cells, Smad7, TGF-β/Smad signaling, extracellular vesicles, tumor microenvironment
- MeSH terms
- Animals, Cell Movement, Epithelium, Female, Humans, Male, Mice, Nude, Middle Aged, Neoplasm Metastasis, Peritoneal Neoplasms, Peritoneum, Stomach Neoplasms, Signal Transduction, Gene Expression Regulation, Neoplastic, Transforming Growth Factor beta, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Mice, Smad7 Protein, Exosomes, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review